Investigational Device Exemption (IDE) application
-
Hospitals
Episurf Medical has received initial feedback from the US FDA on the IDE application for the Episealer® knee implant
MON, JUL 30, 2018 08:30 CET Episurf Medical (NASDAQ: EPIS B) today announces that the company has received initial feedback…
Read More » -
Hospitals
Episurf Medical submits IDE application to the US FDA for the Episealer® knee implant
JUN 28, 2018 Episurf Medical (NASDAQ: EPIS B) today announces that the company has reached an important milestone on its…
Read More »